Regulatory considerations for development of biosimilars in Europe, USA and India
SINDHUJA C.
Regulatory considerations for development of biosimilars in Europe, USA and India - vii,79
NA
Regulatory considerations for development of biosimilars in Europe, USA and India - vii,79
NA